Viewing Study NCT05247203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2026-02-06 @ 12:25 AM
Study NCT ID: NCT05247203
Status: COMPLETED
Last Update Posted: 2023-12-06
First Post: 2022-01-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus
Sponsor: RemeGen Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Systemic Lupus Erythematosus View
None Telitacicept View
None Pharmacokinetics View
None Lupus Erythematosus, Systemic View
None Connective Tissue Diseases View
None Autoimmune Diseases View